The Patent Finder

Chongqing Runze Pharmaceutical Co., Ltd.

11 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

1
Ending by 2030
Sep 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 7, 2027
    The maintenance fee for Preparation method for medical porous tantalum implant material (US 9,072,811) comes due Jan 7, 2027. Unpaid by Jul 7, 2027, it lapses early.
  • 2 fees due Mar 8, 2027
  • 1 fee due Jul 19, 2027
    The maintenance fee for Crystal form I of (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparing method and use thereof (US 9,238,622) comes due Jul 19, 2027. Unpaid by Jan 19, 2028, it lapses early.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Porous material (US 10,597,755) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,238,622Crystal form I of (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparing method and use thereof
In force
 · USPTO record
In forceUSPTO record
US 9,126,9284-hydroxy-2-oxo-1-pyrrolidineacetamide racemate crystal form I and preparation method therefor
In force
 · USPTO record
In forceUSPTO record
US 9,126,929(S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide racemate crystal form II and preparation method therefor
In force
 · USPTO record
In forceUSPTO record
US 9,532,975Use of levo-oxiracetam and oxiracetam in preparation of medicines for preventing or treating coma
In force
 · USPTO record
In forceUSPTO record
US 9,427,268Porous tantalum rod
In force
 · USPTO record
In forceUSPTO record
US 9,072,811Preparation method for medical porous tantalum implant material
In force
 · USPTO record
In forceUSPTO record
US 9,670,156Crystal form III of (S)-oxiracetam, preparation method and use thereof
In force
 · USPTO record
In forceUSPTO record
US 10,597,755Porous material
In force
 · USPTO record
In forceUSPTO record
US 10,835,641Porous material and preparation method thereof
In force
 · USPTO record
In forceUSPTO record
US 10,822,283Porous material and preparation method thereof
In force
 · USPTO record
In forceUSPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 12 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited